Interestingly, Cheema et al. reported on a pathway that directly regulates BCL expression via Par-4 interactions with transcription factor WT1 at the BCL2 gene promoter in prostate cancer cell lines [35]. The gene discussed is PAWR; the disease is prostate carcinoma.